In the rapidly growing field of cannabinoid and ECS-targeting drug development, developers face challenges in sourcing, procuring, and supplying high-quality APIs that meet regulatory standards. The need for innovative drug delivery techniques and robust clinical trial design is more pressing than ever.
At the 8th Cannabinoid & Endocannabinoid Drug Development Summit, we offer a platform for showcasing your customized systems and innovative solutions. Engage with key stakeholders and decision-makers from NeuroTherapia, Ananda Pharma, NaluBio and more. Position your CRO, CDMO, supplier, or consulting services prominently to play a crucial role in driving progress.
With opportunities to present, network one-on-one with stakeholders, and elevate brand visibility, explore a tailored partnership package that aligns with your business objectives, ensuring your solution takes centre stage.
Current Partners:
Experts Need Your Help With:
Why Partner?
1
Build connections with your target audience and secure new business: Connect with senior decision makers from biotech and pharma increasing their spend in cannabinoid R&D and CBR-targeting therapies.
2
Elevate your company’s brand awareness: Explore innovative ways to differentiate your brand and establish yourself as the go-to commercial partner for biotech and pharma entering the cannabinoid and ECS-targeting space.
3
Showcase your solutions and expertise: Capitalize on our highly engaged audience of biopharma stakeholders prioritizing preclinical & clinical research and actively asking for high-level support.
Who Will You Meet?
